These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 18044711)
21. Critical increment of Lewis blood group antigen in serum by cancer found by photothermal immunoassay. Kimura H; Kitamori T; Sawada T Anal Biochem; 1999 Oct; 274(1):98-103. PubMed ID: 10527501 [TBL] [Abstract][Full Text] [Related]
22. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers]. Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599 [TBL] [Abstract][Full Text] [Related]
23. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker]. Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045 [TBL] [Abstract][Full Text] [Related]
24. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822 [TBL] [Abstract][Full Text] [Related]
25. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
26. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965 [TBL] [Abstract][Full Text] [Related]
28. Molecular signature detection of circulating tumor cells using a panel of selected genes. Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer. Müller H; Haug U; Rothenbacher D; Stegmaier C; Brenner H J Urol; 2008 Oct; 180(4):1309-12; discussion 1312-3. PubMed ID: 18707695 [TBL] [Abstract][Full Text] [Related]
30. Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA. El-Masry S; El-Kady I; Zaghloul MH; Al-Badrawey MK Clin Biochem; 2008 Feb; 41(3):145-51. PubMed ID: 18082139 [TBL] [Abstract][Full Text] [Related]
31. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732 [TBL] [Abstract][Full Text] [Related]
32. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008 [TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162 [TBL] [Abstract][Full Text] [Related]
34. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related]
35. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer. Japink D; Leers MP; Sosef MN; Nap M Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342 [TBL] [Abstract][Full Text] [Related]
36. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561 [TBL] [Abstract][Full Text] [Related]
37. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
38. Biomarker CCSA-2 may provide accurate blood test for colorectal cancer. Oncology (Williston Park); 2008 Feb; 22(2):147. PubMed ID: 18409660 [No Abstract] [Full Text] [Related]
39. [Fecal oncomarkers in the diagnostics of colorectal cancer]. Mikhaĭlova EI; Pimanov SI; Voropaev EV Klin Med (Mosk); 2007; 85(12):62-7. PubMed ID: 18318171 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic markers for early detection of ovarian cancer. Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]